Animal experiments have shown that a molecule called "brain supplementation" can reduce anxiety

a key protein molecule in the rhesus monkey brain can reduce anxiety-related behavior, according to a new U.S. study. This is the first such molecule to be found in non-human primate experiments, helping to develop new treatments for diseases such as anxiety and depression.
at the University of California, Davis, and others published their paper in the new issue of the American Journal of Biopsychotics. When the team analyzed the mood-related amygdala backside regions of the brain, they found that a protein molecule called neurotrophic factor-3 may be associated with anxiety.
researchers used modified viruses as vectors to deliver the molecule to the amygdala back of the brains of juvenile rhesus monkeys, and found a decrease in rhesus monkey anxiety-related behavior. Subsequent brain imaging studies of these rhesus monkeys showed that the molecule altered the activity of anxiety-related brain regions.
"Neurotrophic factor-3" is the first molecule found in non-human primates to be causally related to anxiety, and there may be many more molecules that have this effect," said Andrew Fox, an assistant professor in the Department of Psychology at the University of California, Davis, who was involved in the study.
symptoms associated with human anxiety disorders generally begin to show up in adrenament, and adolescents with anxiety disorders are at higher risk of developing mental illness as adults. Current conventional treatments for anxiety disorders are only effective in some patients and can only alleviate certain symptoms. Researchers hope the new findings will help academics develop effective new treatments by deepening their understanding of mental illnesses such as anxiety disorders. (Source: Xinhua News Agency)
relevant paper information: